Brief: Theseus Pharmaceuticals Q2 EPS USD -0.34
10/08/2023 12:07
Aug 10 (Reuters) - Theseus Pharmaceuticals Q2 net income USD -14.805 million. * Q2 operating expenses USD 17.587 million * Q2 EPS USD -0.34 * Q2 income from operations USD -17.587 million
Recent news on Theseus Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Cidara Therapeutics, Senti Bio, Lumentum Holdings
U.S. STOCKS ON THE MOVE-Newmont Corp, Ansys, Karuna Therapeutics
Theseus Pharma rises as Concentra Biosciences agrees to take it private
Brief: Theseus Pharmaceuticals To Be Acquired by Concentra Biosciences
Brief: Theseus Pharmaceuticals Inc Says As Part Of A Reduction In Workforce, Co Terminated Employment Of Timothy P. Clackson, Co's CEO, Effective As Of Dec 7